Allen Buxton

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

Kenneth J. Cohen, Ian F. Pollack, T. Zhou et al. · Neuro-Oncology · 2011 · 397 citations · Full text

Medicine, Oncology, Chemotherapy +16

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

Susan G. Kreissman, Robert C. Seeger, Katherine K. Matthay et al. · The Lancet Oncology · 2013 · 309 citations · Full text

Medicine, Hematology, Oncology +10

Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

David L. Baker, Mary Lou Schmidt, Susan L. Cohn et al. · New England Journal of Medicine · 2010 · 300 citations · Full text

Medicine, Cancer Biology, Oncology +13

Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031

Debra L. Friedman, Lu Chen, Suzanne L. Wolden et al. · Journal of Clinical Oncology · 2014 · 267 citations · Full text

Medicine, Oncology, Pediatrics +16